Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00009178 · ClinicalTrials.gov registry record · NA
Treatment of Bulimia Nervosa in a Primary Care Setting
A NA study, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- Completed
- Registry status
- NA
- Development phase
NCT00009178: Completed NA study, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
NCT00009178 is a NA study that has completed, run by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00009178, a NA study, has completed, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
Bulimia Nervosa is a frequent problem for young women. It is widely assumed that this disorder cannot be treated effectively in a primary care setting. This assumption has never been tested empirically, and is probably incorrect. In the last 15 years, effective treatment interventions for Bulimia Nervosa have been developed and validated in specialized treatment centers. The broad aim of this proposal is to examine whether these treatments, suitably adapted, can be usefully transferred to general health care settings. Specifically, the proposed study will determine the relative and combined effectiveness of the two leading treatments for Bulimia Nervosa in a primary care setting. The two major interventions are treatment with an antidepressant medication, fluoxetine, and with a form of cognitive behavioral therapy, guided self-help, designed for use in primary care.
Interventions
- DRUG Fluoxetine
- BEHAVIORAL Guided Self-Help
Trial Details
| Field | Value |
|---|---|
| Start Date | 1998-03 |
| Est. Completion | 2001-12 |
| Phase | NA |
What the finished NCT00009178 record still lists
NCT00009178 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 2 interventions - of which Fluoxetine is the first listed.
NCT00009178 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00009178 about?
NCT00009178 is a clinical study titled "Treatment of Bulimia Nervosa in a Primary Care Setting". Bulimia Nervosa is a frequent problem for young women. It is widely assumed that this disorder cannot be treated effectively in a primary care setting. This assumption has never been tested empirically, and is probably incorrect. In the last 15 years, effective treatment interventions for Bulimia N...
What is the current status of trial NCT00009178?
This trial is currently completed. It is a NA study. The study started on 1998-03. Estimated completion is 2001-12.
What interventions are being tested in trial NCT00009178?
The interventions under investigation include: Fluoxetine (DRUG), Guided Self-Help (BEHAVIORAL).
Who is sponsoring clinical trial NCT00009178?
This trial is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia